FANJ
COLL icon

Financial Architects (New Jersey)’s Collegium Pharmaceutical COLL Stock Holding History

Financial Architects (New Jersey)’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,428
Closed -$22K – 1241
2019
Q1 		$22K Sell
1,428
-385
-21% -$6.17K ﹤0.01% 856
2018
Q4 		$31K Buy
1,813
+217
+14% +$3.71K 0.01% 670
2018
Q3 		$24K Sell
1,596
-270
-14% -$4.79K ﹤0.01% 870
2018
Q2 		$45K Buy
+1,866
New +$45.9K 0.01% 596

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Financial Architects (New Jersey)'s COLL Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of Collegium Pharmaceutical (COLL) in Q2 2019, closing a stake of 1,428 shares — an estimated $22K sold.

Financial Architects (New Jersey) first reported a position in COLL in Q2 2018 and held it in 4 quarters. The position peaked at $45K in Q2 2018. 128 funds tracked by Wall St. Rank hold COLL as of Q2 2019.

  • Financial Architects (New Jersey) reported no remaining Collegium Pharmaceutical position as of Q2 2019 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 1,428 Collegium Pharmaceutical shares in Q2 2019, an estimated $22K.
  • Financial Architects (New Jersey) first reported a position in Collegium Pharmaceutical in Q2 2018 and held it in 4 quarters.
  • Financial Architects (New Jersey)'s Collegium Pharmaceutical position peaked at $45K in Q2 2018.
  • 128 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.